heart failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Indications for CRTP/CRTD implantation: Heart failure patients with grade II to IV cardiac function after adequate anti-heart failure drug treatment, EF=55mm, complete left bundle branch block or indoor block (QRS>=130ms); 2. Participate in clinical trials voluntarily and sign informed consent; 3. Physical examination, laboratory examination, electrocardiogram and color doppler ultrasound should be performed before the test.
Exclusion criteria
Exclusion criteria: 1. Patients with endless ventricular tachycardia or ventricular fibrillation; 2. Have unstable heart disease, such as acute coronary syndrome; 3. Expected survival <1 year; 4. Clear medical history or other significant diseases of the nervous and psychiatric system, kidney, liver, digestive system, respiratory system, metabolic system and blood system; 5. The researchers considered it inappropriate to participate in the experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiovascular complex endpoints were hospitalization for heart failure, emergency department visits for cardiac reasons, and non-planned outpatient visits for equipment-related problems within 1 year; | — |
Secondary
| Measure | Time frame |
|---|---|
| health-related quality of life;cost-effectiveness;patient satisfaction with their remote follow-up care;pacemaker and lead malfunctions were detected during follow-up; | — |
Countries
China